Beijing Huaxi Pharma

Beijing Huaxi Pharma, widely known as Huaxipharm, is a major pharmaceutical development and manufacturing company based in China. Founded in 2003, the company provides comprehensive services including drug discovery, Chemistry, Manufacturing, and Controls (CMC), and tech transfer for both generic and innovative medicines. Huaxipharm evolved into a full-scale pharmaceutical group through the acquisition of Shandong Huaxi Pharmaceutical, establishing significant manufacturing facilities for active pharmaceutical ingredients (APIs) and solid oral formulations. The company is recognized for its high volume of IND approvals in China and maintains strategic international partnerships, such as its collaboration with Sirona Biochem to bring innovative compounds to the global market. Its portfolio primarily focuses on high-end generics and specialty pharmaceuticals in oncology, endocrinology, and neuroscience.